Optimized Treatment of Peginterferon Alfa 2a/2b in Anti-virus Treatment Naive Patients With HBV Related Liver Fibrosis
Condition(s):Hepatitis B; Liver FibrosisLast Updated:April 19, 2019Unknown status
Hide Studies Not Open or Pending
Condition(s):Hepatitis B; Liver FibrosisLast Updated:April 19, 2019Unknown status
Condition(s):Liver Fibrosis; ChildrenLast Updated:September 29, 2016Completed
Condition(s):NAFLDLast Updated:December 23, 2020Unknown status
Condition(s):Hepatic FibrosisLast Updated:March 6, 2024Not yet recruiting
Condition(s):HCC in Chronic HCV Patients With Advanced Liver FibrosisLast Updated:March 10, 2020Completed
Condition(s):Non-alcoholic Fatty Liver Disease (NAFLD); Alcoholic Liver Disease (ALD); Liver FibrosisLast Updated:December 7, 2023Recruiting
Condition(s):Alcoholic Liver DiseaseLast Updated:October 7, 2009Completed
Condition(s):Liver FibrosisLast Updated:July 27, 2018Completed
Condition(s):Hepatic FibrosisLast Updated:February 9, 2024Recruiting
Condition(s):Chronic Hepatitis CLast Updated:March 7, 2017Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.